Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Molecular Determinant of High-Affinity Dofetilide Binding toHERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites

James P. Lees-Miller, Yanjun Duan, Guo Qi Teng and Henry J. Duff
Molecular Pharmacology February 2000, 57 (2) 367-374;
James P. Lees-Miller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanjun Duan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guo Qi Teng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry J. Duff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

This study reports that the affinity of HERG1 A for dofetilide is decreased from 0.125 ± 0.003 μM for wild-type (WT) channels to 15 ± 3 μM for F656V, a mutation in the COOH-terminal half of the S6. Similarly, the IC50 for quinidine was increased from 8 ± 4 μM for WT to 219 ± 65 μM for the F656V mutation, whereas affinity for external tetraethylammonium was similar for WT (51 ± 10 mM) and F656V (36 ± 10 mM, NS). Kinetics of onset of inactivation of F656V was similar to WT but kinetics of deactivation, activation, and recovery from inactivation differed from WT. However, mutations in nearby amino acids in the S6 more strikingly altered deactivation, activation, and recovery from inactivation but had little effect on affinity for dofetilide. To assess the effects of disruption of inactivation, the S631A mutation was made. The S631A mutation altered the IC50 for dofetilide to 20 ± 3 μM, but the IC50 for quinidine was unchanged at 8 ± 4 μM for WT and 10 ± 1 μM for S631A. To address whether the F656V mutation alters the IC50 for dofetilide in a channel that does not inactivate, the double mutation S631A/F656V was made. The IC50 for dofetilide of the double mutation was 32 ± 3 μM, which is not substantially different than that of S631A. These data support the notion that allosteric changes occurring during the process of inactivation are necessary for high-affinity dofetilide binding. In conclusion, the Phe-656 residue of HERG is a molecular determinant of high-affinity dofetilide binding.

Footnotes

  • Send reprint requests to: H. J. Duff, M.D., F.R.C.P.(C), Department of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta, Canada T2N 4N1. E-mail:hduff{at}ucalgary.ca

  • This work was supported by Medical Research Council of Canada, the Heart and Stroke Foundation of Alberta, and the Andrews Family Professorship in Cardiovascular Medicine.

  • Abbreviations:
    EAG
    ether a-go-go
    WT
    wild type
    TEA
    tetraethylammonium
    TEAe
    external TEA
    4-AP
    4-aminopyridine
    TEAe
    tetraethylammonium external
    • Received July 28, 1999.
    • Accepted November 9, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (2)
Molecular Pharmacology
Vol. 57, Issue 2
1 Feb 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Determinant of High-Affinity Dofetilide Binding toHERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
Citation Tools
Research ArticleArticle

Molecular Determinant of High-Affinity Dofetilide Binding toHERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites

James P. Lees-Miller, Yanjun Duan, Guo Qi Teng and Henry J. Duff
Molecular Pharmacology February 1, 2000, 57 (2) 367-374;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Molecular Determinant of High-Affinity Dofetilide Binding toHERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites

James P. Lees-Miller, Yanjun Duan, Guo Qi Teng and Henry J. Duff
Molecular Pharmacology February 1, 2000, 57 (2) 367-374;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Operational Models for Receptors with Multiple Agonist Sites
  • BODIPY-cyclopamine Binding to Nluc-SMO
  • Characterization and optimization of the novel TRPM2 antagonist tatM2NX
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics